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Objective. Central giant cell lesion (CGCL) and giant cell tumour (GCT) are bone lesions that share similar microscopic
features. Recently, it was reported that 90% of bone GCT exhibit either p.Gly34 Trp or p.Gly34 Leu in H3F3A, one of two
genes for histone H3.3 located on chromosome 1. We aimed to test whether sporadic CGCL of the jaws share the H3F3A
mutations reported in GCT of other bones.
Methods. Nine samples of CGCL of the jaws were included in the study, and mutations were assessed by direct sequencing.
Results. None of the CGCL samples presented the recurrent p.Gly34 Trp or p.Gly34 Leu mutations in the H3F3A gene.
Conclusion. On the basis of our findings, H3F3A p.Gly34 Trp or p.Gly34 Leu mutations are not a frequent event in CGCL. If
these alterations are confirmed to be exclusive of GCT, the assessment of H3F3A mutations may help in the differential
diagnosis of GCT and CGCL of the jaws. (Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:583-585)Table I. Clinical data of the CGCL and cherubism
samples included in the study
Diagnosis Age (y) Sex Location Aggressive*
CGCL
#1 11 Male Body of mandible Yes
#2 26 Female Body of mandible Yes
#3 25 Female Body of mandible Yes
#4 23 Female Body of mandible Yes
#5 28 Female Mandibular symphysis Yes
#6 27 Male Body of mandible No
#7 5 Female Body of mandible No
#8 27 Male Body of mandible Yes
#9 28 Female Mandibular symphysis No
CGCL, Central giant cell lesion of the jaws; yes, aggressive lesions;
no, non-aggressive lesions.
*The aggressiveness of sporadic CGCL was assessed as previously
reported.9 Aggressive cases were larger than 4 cm and presented
damaged or expanded cortical bone and tooth displacement.Various bone lesions of the jaws may present multi-
nucleated giant cells in a background of ovoid to
spindle-shaped cells. Central giant cell lesion (CGCL)
and giant cell tumour (GCT) are examples of pathologic
processes that share similar microscopic features.
CGCL affects mainly the anterior portion of the
mandible of young or adult patients.1 In contrast, GCT
is a locally aggressive neoplasm that is primarily
located in the metaphysis of long bones.2
Cytogenetic studies have found t(1; 18; 18)(p13;
q11.2; q21) and t(2; 10)(q23; q24) translocations in
isolated cases of CGCL of the jaws, but scarce mo-
lecular alterations are reported.3,4 GCT of other bones
may present chromosomal instability and various
non-recurrent cytogenetic aberrations together with
consistent clonal telomeric alterations.5 A recent study
identiﬁed recurrent p.Gly34 Trp or p.Gly34 Leu
mutations in the H3F3A gene, which encodes the
replication-independent histone H3.3, in 49 out of 53
cases of bone GCT.6 As the authors also identiﬁed
distinct alterations involving one of the two genes for
histone H3.3, H3F3A and H3F3B, in a variety of bone
and cartilage tumours, they proposed that this mutation
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of them may be misdiagnosed as aggressive CGCL.
Considering that GCT and CGCL have overlapping
clinical, radiographic and histopathologic features, but
distinct biological behaviour, molecular markers may
be useful for their differential diagnosis. These markers
may also be relevant to the understanding of the path-
ogenesis of these pathologic conditions. Therefore, the
aim of this study is to test whether CGCL of the jawsStatement of Clinical Relevance
H3F3A gene mutation has recently been reported in
a high proportion of giant cell tumours of long
bones. We show that sporadic central giant cell le-
sions of the jaws do not present such mutation,
which may be useful in distinguishing these entities.
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Fig. 1. Histopathologic photomicrograph (H&E stain, original magniﬁcation x40) (A) and mutation evaluation (B) in CGCL cases
#1, #2 and #9, respectively. Figure B shows a screen shot of the electropherogram of the CGCL cases demonstrating a H3F3A
wild-type glycine 34 codon. (CGCL, central giant cell lesion).
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as was recently reported for GCT of other bones.METHODS
Samples
A total of nine samples of CGCL of the jaws, including
six aggressive cases, were included in this study
(Table I). The CGCL samples were collected at the time
of surgery. A section of the CGCL sample fragment
was immediately snap-frozen and stored at 80C. The
other section was formalin ﬁxed, and the clinical
diagnosis was histologically conﬁrmed by routine H&E
staining. The local ethics committee approved this
study, and signed informed consent was obtained.DNA extraction and direct sequencing
Genomic DNA was extracted from the fresh samples
using the DNeasy Blood and Tissue Kit (Qiagen,
Hilden, Germany) and from the parafﬁn-embedded
tissues using QIamp DNA FFPE Tissue Kit (Qiagen)
according to the manufacturer’s instructions.
As 92% of GCT of bone exhibited either p.Gly34
Trp or p.Gly34 Leu in H3F3A,6 one of two genes for
histone H3.3 located on chromosome 1 (ENSEMBL
ENST00000366815), we designed a set of primers
ﬂanking this region using PrimereBLAST. The primers
sequences were as follows: Forward, 50CATGG
CTCGTACAAAGCAGA30, and reverse, 50GCAAA
AAGTTTTCCTGTTATCCA 30. The polymerase chain
reaction (PCR) reactions were performed in a ﬁnal
volume of 30 ml containing 200 ng template DNA,200 mM dNTPs, 10 pM each primer and 1.25 U
proofreading Taq polymerase (Platinum_ Taq DNA
Polymerase High Fidelity; Invitrogen, Carlsbad, CA).
The PCR reactions were carried out in a thermocycler
with appropriate parameters. The PCR products were
conﬁrmed by electrophoresis through a 6.5% poly-
acrylamide gel, silver stained and puriﬁed using the
GFX PCR DNA (Amersham Biosciences, Piscataway,
NJ, USA). DNA sequencing reactions were carried out
using Big Dye Terminator Kit with a DNA ABI PRISM
3130 Genetic Analyzer (Applied Biosystems, Foster
City, CA, USA).
RESULTS
The recurrent H3F3A p.Gly34 Trp or p.Gly34 Leu
mutations previously reported in bone GCT were not
found in any of the CGCL investigated (Figure 1).
DISCUSSION
The packaging of DNA into chromatin in eukaryotes is
promoted by histones. It has been found that the pres-
ence of mutant H.3 histone disrupts epigenetic post-
translational modiﬁcations in genes involved in cancer
processes.7 In humans, there are two genes, H3F3A and
H3F3B, which produce identical H3.3 proteins.8 Beh-
jati et al.6 identiﬁed distinct histone H3.3 alterations in a
variety of bone and cartilage tumours. These authors
found clear tumour type preferences for H3F3B muta-
tions in chondroblastoma and H3F3A alterations in
GCT. Because of the similar microscopic presentation
of CGCL of the jaws with GCT, we searched for the
same mutation in lesions of the former. We expected to
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nosis of bone lesions containing giant cells.
Our result did not reveal the H3F3A p.Gly34 Trp or
p.Gly34 Leu mutations in sporadic CGCL of the jaws.
Although studies including additional bone lesions are
necessary, our results support the molecular investiga-
tion of the H3F3A gene in the differential diagnosis of
CGCL with GCT. If this alteration is conﬁrmed to be
exclusive of GCT, this ﬁnding also contributes to the
clariﬁcation of the pathogenesis of both conditions.REFERENCES
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